AISAP Cardio vs EchoGo® Heart Failure
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 70/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
AISAP Cardio offers a comprehensive point-of-care solution for broad cardiac assessments, including structural heart disease and general heart failure detection. In contrast, EchoGo® Heart Failure is a specialized AI platform designed specifically for the detection of Heart Failure with preserved Ejection Fraction (HFpEF) from routine echocardiograms. Therefore, while both leverage AI for cardiac echo analysis, their primary focus and breadth of diagnostic capabilities differ.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
AISAP Cardio is designed for rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside, including various valvular pathologies. EchoGou00ae Heart Failure, on the other hand, is an AI platform specifically focused on analyzing routine echocardiograms to detect Heart Failure with preserved Ejection Fraction (HFpEF).
Both AISAP Cardio and EchoGou00ae Heart Failure are cloud-based platforms designed for seamless integration with existing clinical workflows, EHR/EMR, and PACS. EchoGou00ae Heart Failure specifically mentions a DICOM workflow for report delivery to PACS, while AISAP Cardio also integrates with existing clinical workflows, EHR/EMR, and PACS.
AISAP Cardio provides a comprehensive cardiac ultrasound software package that includes assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), Left Ventricle Ejection Fraction (LVEF), right and left ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. EchoGou00ae Heart Failure focuses on AI-powered HFpEF detection by analyzing routine echo video clips and delivering insights to support clinical decisions.
EchoGou00ae Heart Failure is reimbursable via CPT code 0932T for outpatient analysis, with a national Medicare average of $316 per analysis, and is covered by Medicare and select commercial insurers. Pricing for AISAP Cardio is not publicly available, and interested parties need to contact the company for demo and pricing information.
EchoGou00ae Heart Failure delivers insights within 20 minutes after analyzing routine echo video clips. AISAP Cardio is described as providing 'rapid' assessments and generating accurate reports in minutes, allowing clinicians to accurately diagnose common cardiac parameters at the bedside within minutes.
AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform, designed to integrate with portable ultrasound devices for fast diagnostics directly at the patient's bedside. EchoGou00ae Heart Failure analyzes routine echocardiogram video clips, specifically a single apical 4-chamber view from a standard transthoracic echocardiogram (TTE) examination.
EchoGou00ae Heart Failure is clinically validated with 90% sensitivity and 86% specificity for HFpEF, and was trained on over 10 years of outcome data. AISAP Cardio's platform achieved 93% sensitivity and specificity for detecting significant valve disease, and studies showed it enables non-cardiologist physicians to interpret point-of-care echocardiograms as accurately as expert cardiologists.